Join the Sustainable HIV Prevention Initiative and partners for a webinar, “At a Crossroads: Reimagi...
Event Details
The Communities Delegation to the Unitaid Board represents the voices of people living with and affected by HIV, tuberculosis, malaria, and other global health challenges. The Delegation ensures that the perspectives of communities most impacted by diseases are reflected in Unitaid’s governance, strategies, and investments.
Every story reflects resilience, innovation, and hope. These lived experiences remind us why community voices matter.
Zambia's SCALE-IT project trains community health workers to deliver lenacapavir, a 6-month HIV-prevention injection, directly in markets and homes—re...
A pre-eclampsia survivor shares her journey and calls for stronger maternal healthcare systems to prevent avoidable maternal and newborn deaths.
Malaria progress is at risk despite community-led innovations. Sustained political will, funding, and global solidarity are critical to prevent setbac...
From awareness walks to storytelling nights, our events shine a light on resilience, celebrate milestones, and unite communities in hope and joy.
Join the Sustainable HIV Prevention Initiative and partners for a webinar, “At a Crossroads: Reimagi...
Event Details
Join the Diagnostics Equity Consortium (DEC) for the second session of a two-part Study Club Series...
Event Details
Despite progress over the past two decades, maternal and newborn health outcomes remain uneven, with...
Event DetailsStay informed with the latest news, project highlights, and advocacy updates from our organization. Discover how we’re creating lasting change in the communities we serve.
La Délégation des Communautés met en avant l’accès équitable aux soins, la participation communautaire et le rôle d’Unitaid dans l’innovation en santé...
Read MoreUnitaid is investing US$36 million to scale malaria prevention tools, funding evidence on spatial emanators and insecticide-treated baby wraps to guid...
Read MoreUnitaid welcomes African manufacturing investment for alimatravir but urges Merck to expand its 129-country license to cover excluded middle-income na...
Read More